• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素受体在肝脏中独立于成纤维细胞生长因子21调节大多数基因。

Thyroid hormone receptor regulates most genes independently of fibroblast growth factor 21 in liver.

作者信息

Zhang Aijun, Sieglaff Douglas H, York Jean Philippe, Suh Ji Ho, Ayers Stephen D, Winnier Glenn E, Kharitonenkov Alexei, Pin Christopher, Zhang Pumin, Webb Paul, Xia Xuefeng

机构信息

Houston Methodist Research InstituteGenomic Medicine Program, 6670 Bertner Ave, Houston, Texas 77030, USACollege of Arts and SciencesChemistry Department, Indiana University Bloomington, Bloomington, Indiana, USADepartments of PaediatricsOncology, and Physiology and Pharmacology, University of Western Ontario, London, Ontario, CanadaChildren's Health Research InstituteLondon, Ontario, CanadaDepartment of Molecular Physiology and BiophysicsBaylor College of Medicine, Houston, Texas, USAThe Third Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, China.

Houston Methodist Research InstituteGenomic Medicine Program, 6670 Bertner Ave, Houston, Texas 77030, USACollege of Arts and SciencesChemistry Department, Indiana University Bloomington, Bloomington, Indiana, USADepartments of PaediatricsOncology, and Physiology and Pharmacology, University of Western Ontario, London, Ontario, CanadaChildren's Health Research InstituteLondon, Ontario, CanadaDepartment of Molecular Physiology and BiophysicsBaylor College of Medicine, Houston, Texas, USAThe Third Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, China Houston Methodist Research InstituteGenomic Medicine Program, 6670 Bertner Ave, Houston, Texas 77030, USACollege of Arts and SciencesChemistry Department, Indiana University Bloomington, Bloomington, Indiana, USADepartments of PaediatricsOncology, and Physiology and Pharmacology, University of Western Ontario, London, Ontario, CanadaChildren's Health Research InstituteLondon, Ontario, CanadaDepartment of Molecular Physiology and BiophysicsBaylor College of Medicine, Houston, Texas, USAThe Third Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, China.

出版信息

J Endocrinol. 2015 Mar;224(3):289-301. doi: 10.1530/JOE-14-0440. Epub 2014 Dec 11.

DOI:10.1530/JOE-14-0440
PMID:25501997
Abstract

Thyroid hormone (TH) acts through specific receptors (TRs), which are conditional transcription factors, to induce fibroblast growth factor 21 (FGF21), a peptide hormone that is usually induced by fasting and that influences lipid and carbohydrate metabolism via local hepatic and systemic endocrine effects. While TH and FGF21 display overlapping actions when administered, including reductions in serum lipids, according to the current models these hormones act independently in vivo. In this study, we examined mechanisms of regulation of FGF21 expression by TH and tested the possibility that FGF21 is required for induction of hepatic TH-responsive genes. We confirm that active TH (triiodothyronine (T3)) and the TRβ-selective thyromimetic GC1 increase FGF21 transcript and peptide levels in mouse liver and that this effect requires TRβ. T3 also induces FGF21 in cultured hepatocytes and this effect involves direct actions of TRβ1, which binds a TRE within intron 2 of FGF21. Gene expression profiles of WT and Fgf21-knockout mice are very similar, indicating that FGF21 is dispensable for the majority of hepatic T3 gene responses. A small subset of genes displays diminished T3 response in the absence of FGF21. However, most of these are not obviously directly involved in T3-dependent hepatic metabolic processes. Consistent with these results, T3-dependent effects on serum cholesterol are maintained in the Fgf21(-/-) background and we observe no effect of the Fgf21-knockout background on serum triglycerides and glucose. Our findings indicate that T3 regulates the genes involved in classical hepatic metabolic responses independently of FGF21.

摘要

甲状腺激素(TH)通过特异性受体(TRs)发挥作用,TRs是条件性转录因子,可诱导成纤维细胞生长因子21(FGF21),FGF21是一种肽类激素,通常由禁食诱导产生,并通过局部肝脏和全身内分泌作用影响脂质和碳水化合物代谢。虽然TH和FGF21在给药时表现出重叠作用,包括降低血清脂质,但根据目前的模型,这些激素在体内独立发挥作用。在本研究中,我们研究了TH对FGF21表达的调控机制,并测试了FGF21是否是诱导肝脏TH反应性基因所必需的。我们证实活性TH(三碘甲状腺原氨酸(T3))和TRβ选择性甲状腺模拟物GC1可增加小鼠肝脏中FGF21转录本和肽水平,且这种作用需要TRβ。T3还可在培养的肝细胞中诱导FGF21,这种作用涉及TRβ1的直接作用,TRβ1与FGF21内含子2中的甲状腺激素反应元件(TRE)结合。野生型(WT)和Fgf21基因敲除小鼠的基因表达谱非常相似,表明FGF21对于大多数肝脏T3基因反应并非必需。在缺乏FGF21的情况下,一小部分基因的T3反应减弱。然而,其中大多数基因显然并不直接参与T3依赖的肝脏代谢过程。与这些结果一致,在Fgf21(-/-)背景下,T3对血清胆固醇的依赖性作用得以维持,并且我们观察到Fgf21基因敲除背景对血清甘油三酯和葡萄糖没有影响。我们的研究结果表明,T3独立于FGF21调节参与经典肝脏代谢反应的基因。

相似文献

1
Thyroid hormone receptor regulates most genes independently of fibroblast growth factor 21 in liver.甲状腺激素受体在肝脏中独立于成纤维细胞生长因子21调节大多数基因。
J Endocrinol. 2015 Mar;224(3):289-301. doi: 10.1530/JOE-14-0440. Epub 2014 Dec 11.
2
Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.甲状腺激素通过 PPARα 依赖性方式调节肝组织中纤维母细胞生长因子 21 的表达。
J Biol Chem. 2010 May 7;285(19):14078-82. doi: 10.1074/jbc.C110.107375. Epub 2010 Mar 17.
3
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo.成纤维细胞生长因子 21 和甲状腺激素表现出相互的调节依赖性,但在体内具有独立的作用。
Endocrinology. 2014 May;155(5):2031-40. doi: 10.1210/en.2013-1902. Epub 2014 Feb 24.
4
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells.TRβ 是 T3 诱导肝细胞和胰腺腺泡细胞增殖的关键甲状腺激素受体同工型。
J Hepatol. 2010 Oct;53(4):686-92. doi: 10.1016/j.jhep.2010.04.028. Epub 2010 Jul 1.
5
Changes in Hepatic TRβ Protein Expression, Lipogenic Gene Expression, and Long-Chain Acylcarnitine Levels During Chronic Hyperthyroidism and Triiodothyronine Withdrawal in a Mouse Model.慢性甲状腺功能亢进症及三碘甲状腺原氨酸撤除过程中,在小鼠模型中肝 TRβ 蛋白表达、生脂基因表达和长链酰基辅酶 A 水平的变化。
Thyroid. 2017 Jun;27(6):852-860. doi: 10.1089/thy.2016.0456. Epub 2017 May 24.
6
Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.甲状腺激素抵抗小鼠模型中的多组织基因表达分析
Genome Biol. 2004;5(5):R31. doi: 10.1186/gb-2004-5-5-r31. Epub 2004 Apr 29.
7
FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.FGF21 通过在长时间禁食期间介导肝脏和大脑之间的串扰来维持葡萄糖稳态。
Diabetes. 2014 Dec;63(12):4064-75. doi: 10.2337/db14-0541. Epub 2014 Jul 14.
8
Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.蛋白质营养不良时成纤维细胞生长因子21的快速增加及其对生长和脂质代谢的影响。
Br J Nutr. 2015 Nov 14;114(9):1410-8. doi: 10.1017/S0007114515002846. Epub 2015 Sep 2.
9
Patterns of liver gene expression governed by TRbeta.
Mol Endocrinol. 2002 Jun;16(6):1257-68. doi: 10.1210/mend.16.6.0846.
10
Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet.肝 X 受体负调控富含胆固醇饮食诱导的脂肪肝中纤维母细胞生长因子 21 的表达。
J Nutr Biochem. 2012 Jul;23(7):785-90. doi: 10.1016/j.jnutbio.2011.03.023. Epub 2011 Sep 1.

引用本文的文献

1
Sex Differences in Ketogenic Diet Response Reveal Gonadal Hormone Interaction With FGF21 in Mice.生酮饮食反应中的性别差异揭示了小鼠性腺激素与成纤维细胞生长因子21的相互作用。
J Endocr Soc. 2025 Aug 18;9(10):bvaf131. doi: 10.1210/jendso/bvaf131. eCollection 2025 Oct.
2
Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.左甲状腺素替代治疗的桥本甲状腺炎患者血清成纤维细胞生长因子21水平降低及其受甲状腺激素的调节变化
Metabolites. 2024 Oct 21;14(10):565. doi: 10.3390/metabo14100565.
3
Lipid Metabolism in Pregnancy Women with Hypothyroidism and Potential Influence on Pregnancy Outcome.
甲状腺功能减退孕妇的脂质代谢及其对妊娠结局的潜在影响。
J Lipids. 2024 Jul 9;2024:5589492. doi: 10.1155/2024/5589492. eCollection 2024.
4
ATF4/TXNIP/REDD1/mTOR signaling mediates the antitumor activities of liver X receptor in pancreatic cancers.ATF4/TXNIP/REDD1/mTOR信号通路介导肝脏X受体在胰腺癌中的抗肿瘤活性。
Cancer Innov. 2022 Jun 30;1(1):55-69. doi: 10.1002/cai2.12. eCollection 2022 Jun.
5
Fibroblast growth factor 21 in metabolic syndrome.成纤维细胞生长因子 21 与代谢综合征。
Front Endocrinol (Lausanne). 2023 Jul 27;14:1220426. doi: 10.3389/fendo.2023.1220426. eCollection 2023.
6
FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism.快速放射性碘诱导甲状腺功能减退症后,脂肪生成增加状态下释放 FGF21。
Front Endocrinol (Lausanne). 2022 Jul 14;13:900034. doi: 10.3389/fendo.2022.900034. eCollection 2022.
7
Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology.2型糖尿病与甲状腺病理生理学交叉点上的硒与硒蛋白
Antioxidants (Basel). 2022 Jun 16;11(6):1188. doi: 10.3390/antiox11061188.
8
Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism.甲状腺功能减退症血脂异常的最新进展:甲状腺功能减退症血脂异常的机制
Endocr Connect. 2022 Feb 7;11(2):e210002. doi: 10.1530/EC-21-0002.
9
Serum Fibroblast Growth Factor 21 Levels in Children and Adolescents with Hashimoto's Thyroiditis before and after l-Thyroxin Medication: A Prospective Study.血清成纤维细胞生长因子 21 水平在桥本甲状腺炎患儿和青少年甲状腺素治疗前后:一项前瞻性研究。
Medicina (Kaunas). 2021 Dec 17;57(12):1374. doi: 10.3390/medicina57121374.
10
Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism.探讨甲状腺功能减退症患者血脂异常病理发展的新见解。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):326-339. doi: 10.17305/bjbms.2021.6606.